Jerome F. Strauss III

Prof. Jerome F. Strauss III

Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2019 in Nature
Verified
Journal Article
Open access
PDF file
TCThe Integrative HMP (iHMP) Research Network Consortium
The Integrative HMP (iHMP) Research Network Consortium
LPLita M. Proctor
Lita M. Proctor
HCHeather H. Creasy
Heather H. Creasy
JFJennifer M. Fettweis
Jennifer M. Fettweis
JLJason Lloyd-Price
Jason Lloyd-Price
CHCurtis Huttenhower
Curtis Huttenhower
The NIH Human Microbiome Project (HMP) has been carried out over ten years and two phases to provide resources, methods, and discoveries that link interactions between humans and their microbiomes to health-related outcomes. The recently completed second phase, the Integrative Human Microbiome Project, comprised studies of dynamic changes in the microbiome and host under three conditions: pregnancy and preterm birth; inflammatory bowel diseases; and stressors that affect individuals with prediabetes. The associated research begins to elucidate mechanisms of host–microbiome interactions under these conditions, provides unique data resources (at the HMP Data Coordination Center), and represents a paradigm for future multi-omic studies of the human microbiome.

1 March 2018 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
Jerome F. Strauss IIIJerome F. Strauss III
Jerome F. Strauss III
RRRoberto Romero
Roberto Romero
NGNardhy Gomez-Lopez
Nardhy Gomez-Lopez
HHHannah Haymond-Thornburg
Hannah Haymond-Thornburg
BMBhavi P. Modi
Bhavi P. Modi
HSHarvey A. Schenkein
Harvey A. Schenkein


22 March 2021 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
MPMaría M Pereira
María M Pereira
MMMonica Mainigi
Monica Mainigi
Jerome F. Strauss IIIJerome F. Strauss III
Jerome F. Strauss III
BACKGROUND: Despite significant advances in our understanding of the pathophysiology of preeclampsia (PE), there are still many unknowns and controversies in the field. Women undergoing frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium have been found to have an unexpected increased risk of PE compared to women who receive embryos in a natural FET cycle. The differences in risk have been hypothesized to be related to the absence or presence of a functioning corpus luteum (CL). OBJECTIVE AND RATIONALE: To evaluate the literature on secretory products of the CL that could be essential for a healthy pregnancy and could reduce the risk of PE in the setting of FET. SEARCH METHODS: For this review, pertinent studies were searched in PubMed/Medline (updated June 2020) using common keywords applied in the field of assisted reproductive technologies, CL physiology and preeclampsia. We also screened the complete list of references in recent publications in English (both animal and human studies) on the topics investigated. Given the design of this work as a narrative review, no formal criteria for study selection or appraisal were utilized. OUTCOMES: The CL is a major source of multiple factors regulating reproduction. Progesterone, estradiol, relaxin and vasoactive and angiogenic substances produced by the CL have important roles in regulating its functional lifespan and are also secreted into the circulation to act remotely during early stages of pregnancy. Beyond the known actions of progesterone and estradiol on the uterus in early pregnancy, their metabolites have angiogenic properties that may optimize implantation and placentation. Serum levels of relaxin are almost undetectable in pregnant women without a CL, which precludes some maternal cardiovascular and renal adaptations to early pregnancy. We suggest that an imbalance in steroid hormones and their metabolites and polypeptides influencing early physiologic processes such as decidualization, implantation, angiogenesis and maternal haemodynamics could contribute to the increased PE risk among women undergoing programmed FET cycles. WIDER IMPLICATIONS: A better understanding of the critical roles of the secretory products of the CL during early pregnancy holds the promise of improving the efficacy and safety of ART based on programmed FET cycles.

Verified
Journal Article
Open access
PDF file
SESummer Elshenawy
Summer Elshenawy
SPSara Pinney
Sara Pinney
TSTami Stuart
Tami Stuart
PDPaschalis-Thomas Doulias
Paschalis-Thomas Doulias
GZGabriella Zura
Gabriella Zura
RSRebecca Simmons
Rebecca Simmons
The placenta is metabolically active and supports the growth of the fetus. We hypothesize that deficits in the capacity of the placenta to maintain bioenergetic and metabolic stability during pregnancy may result in spontaneous preterm birth (SPTB). To explore this hypothesis, we performed a nested cased control study of metabolomic signatures in placentas from women with SPTB (<36 weeks gestation) compared to normal pregnancies (≥38 weeks gestation). To control for the effects of gestational age on placenta metabolism, we also studied a subset of metabolites in non-laboring preterm and term Rhesus monkeys. Comprehensive quantification of metabolites demonstrated a significant elevation in the levels of amino acids, prostaglandins, sphingolipids, lysolipids, and acylcarnitines in SPTB placenta compared to term placenta. Additional quantification of placental acylcarnitines by tandem mass spectrometry confirmed the significant elevation in SPTB human, with no significant differences between midgestation and term placenta in Rhesus macaque. Fatty acid oxidation as measured by the flux of 3H-palmitate in SPTB placenta was lower than term. Collectively, significant and biologically relevant alterations in the placenta metabolome were identified in SPTB placenta. Altered acylcarnitine levels and fatty acid oxidation suggest that disruption in normal substrate metabolism is associated with SPTB.

19 January 2016 in Cytoskeleton
Verified
Journal Article
Open access
PDF file
MTMaria E. Teves
Maria E. Teves
DNDavid R. Nagarkatti‐Gude
David R. Nagarkatti‐Gude
ZZZhibing Zhang
Zhibing Zhang
Jerome F. Strauss IIIJerome F. Strauss III
Jerome F. Strauss III
The axoneme genes, their encoded proteins, their functions and the structures they form are largely conserved across species. Much of our knowledge of the function and structure of axoneme proteins in cilia and flagella is derived from studies on model organisms like the green algae, Chlamydomonas reinhardtii. The core structure of cilia and flagella is the axoneme, which in most motile cilia and flagella contains a 9 + 2 configuration of microtubules. The two central microtubules are the scaffold of the central pair complex (CPC). Mutations that disrupt CPC genes in Chlamydomonas and other model organisms result in defects in assembly, stability and function of the axoneme, leading to flagellar motility defects. However, targeted mutations generated in mice in the orthologous CPC genes have revealed significant differences in phenotypes of mutants compared to Chlamydomonas. Here we review observations that support the concept of cell‐type specific roles for the CPC genes in mice, and an expanded repertoire of functions for the products of these genes in cilia, including non‐motile cilia, and other microtubule‐associated cellular functions.